Complement Levels Vary in irAE-n and Controls
Physician's Weekly
JUNE 29, 2025
They enrolled individuals diagnosed with irNeuropathy or irMyositis, along with cancer control s (CCs) and healthy controls (HCs). Spearman’s correlation was used to examine the relationships between complement levels, severity, and clinical outcomes of immune-related neurologic adverse events (irAE-n).
Let's personalize your content